Unexpected high incidence of severe toxicities associated with alpha interferon, low-dose cytosine arabinoside and all-trans retinoic acid in patients with chronic myelogenous leukemia.

MLA

Sacchi, S., et al. “Unexpected High Incidence of Severe Toxicities Associated with Alpha Interferon, Low-Dose Cytosine Arabinoside and All-Trans Retinoic Acid in Patients with Chronic Myelogenous Leukemia.” Leukemia & Lymphoma, vol. 35, no. 5–6, Nov. 1999, pp. 483–89. EBSCOhost, https://doi.org/10.1080/10428199909169612.

APA

Sacchi, S., Kantarjian, H. M., Freireich, E. J., O’Brien, S., Cortes, J., Rios, M. B., Kornblau, S., Giles, F. J., Koller, C., Gajewski, J., & Talpaz, M. (1999). Unexpected high incidence of severe toxicities associated with alpha interferon, low-dose cytosine arabinoside and all-trans retinoic acid in patients with chronic myelogenous leukemia. Leukemia & Lymphoma, 35(5–6), 483–489. https://doi.org/10.1080/10428199909169612

Chicago

Sacchi, S, H M Kantarjian, E J Freireich, S O’Brien, J Cortes, M B Rios, S Kornblau, et al. 1999. “Unexpected High Incidence of Severe Toxicities Associated with Alpha Interferon, Low-Dose Cytosine Arabinoside and All-Trans Retinoic Acid in Patients with Chronic Myelogenous Leukemia.” Leukemia & Lymphoma 35 (5–6): 483–89. doi:10.1080/10428199909169612.